 SAN DIEGO and SUZHOU, China, Jan. 05, 2023 GLOBE NEWSWIRE -- Adagene Inc. Adagene Nasdaq: ADAG, a company transforming the discovery and development of antibody-based therapies, today announced that Adagenes Co-founder, Chief Executive Officer and Chairman, Peter Luo, Ph.D., will provide a corporate update at the Biotech ShowcaseTM 2023, taking place January 9-11th in San Francisco, in parallel to the annual J.P. Morgan Healthcare Conference. 